0001731122-24-000268.txt : 20240216 0001731122-24-000268.hdr.sgml : 20240216 20240216094403 ACCESSION NUMBER: 0001731122-24-000268 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240213 FILED AS OF DATE: 20240216 DATE AS OF CHANGE: 20240216 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Binette Francois CENTRAL INDEX KEY: 0001940686 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38758 FILM NUMBER: 24646045 MAIL ADDRESS: STREET 1: 2022 N. ALVARADO STREET CITY: LOS ANGELES STATE: CA ZIP: 90039 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RENOVARO INC. CENTRAL INDEX KEY: 0001527728 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 452259340 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: CENTURY CITY MEDICAL PLAZA STREET 2: 2080 CENTURY CITY EAST CITY: SUITE 906 LOS ANGELES STATE: CA ZIP: 90067 BUSINESS PHONE: 45 39179840 MAIL ADDRESS: STREET 1: CENTURY CITY MEDICAL PLAZA STREET 2: 2080 CENTURY CITY EAST CITY: SUITE 906 LOS ANGELES STATE: CA ZIP: 90067 FORMER COMPANY: FORMER CONFORMED NAME: RENOVARO BIOSCIENCES INC. DATE OF NAME CHANGE: 20230807 FORMER COMPANY: FORMER CONFORMED NAME: Enochian Biosciences Inc. DATE OF NAME CHANGE: 20230804 FORMER COMPANY: FORMER CONFORMED NAME: Renovaro Biosciences Inc. DATE OF NAME CHANGE: 20230802 4 1 ownership.xml X0508 4 2024-02-13 0 0001527728 RENOVARO INC. RENB 0001940686 Binette Francois C/O RENOVARO BIOSCIENCES INC. 9480 NE 2ND AVENUE #73 MIAMI FL 33138 0 1 0 0 COO and Executive VP for R&D 0 Option to Purchase Common Stock 2.38 2024-02-13 4 D 0 65000 D 2032-07-22 Common Stock 65000 0 D Option to Purchase Common Stock 1.92 2024-02-13 4 A 0 65000 A 2024-02-13 2032-07-22 Common Stock 65000 65000 D Option to Purchase Common Stock 8.40 2024-02-13 4 D 0 65000 D 2023-04-18 2032-02-22 Common Stock 65000 0 D Option to Purchase Common Stock 1.92 2024-02-13 4 A 0 65000 A 2024-02-13 2032-02-22 Common Stock 65000 65000 D Option to Purchase Common Stock 2.15 2024-02-13 4 D 0 40000 D 2032-10-18 Common Stock 40000 0 D Option to Purchase Common Stock 1.92 2024-02-13 4 A 0 40000 A 2032-10-18 Common Stock 40000 40000 D 60% of the option vested on January 22, 2023 and 40% on July 22, 2023. The transactions reported herein reflect a stock option repricing (the "Option Repricing") effective on February 13, 2024 (the "Repricing Date"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the "Common Stock"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options. One-third of the option vested on October 18, 2023. The remainder of the option vests equally on October 18, 2024 and October 18, 2025. /s/ Francois Binette 2024-02-16